Baird Mid Cap Growth Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Baird Mid Cap Growth Fund Investor Class BMDSX
- NAV / 1-Day Return 17.19 / +0.76 %
- Total Assets 447.0M
-
Adj. Expense Ratio
1.100%
- Expense Ratio 1.070%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 63%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0
Morningstar’s Analysis BMDSX
Will BMDSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 24.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
First American Government Obligs U | 23.08 | 112M | Cash and Equivalents |
Victoria's Secret & Co | 2.89 | 14M | Consumer Cyclical |
Fastenal Co | 2.87 | 14M | Industrials |
XPO Inc | 2.63 | 13M | Industrials |
Illumina Inc | 2.47 | 12M | Healthcare |
Repligen Corp | 2.46 | 12M | Healthcare |
MSCI Inc | 2.39 | 12M | Financial Services |
Veeva Systems Inc Class A | 2.33 | 11M | Healthcare |
Heico Corp | 2.27 | 11M | Industrials |
DexCom Inc | 2.25 | 11M | Healthcare |